These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3286064)

  • 1. Growth hormone (GH) secretion during nocturnal sleep and after clonidine in patients with essential hypertension.
    Słowińska-Srzednicka J; Zgliczyński S; Wierzbicki M; Soszyński P; Jeske W
    Clin Exp Hypertens A; 1988; 10(2):187-202. PubMed ID: 3286064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clonidine on serum inorganic phosphorus in patients with essential arterial hypertension.
    Uza G
    J Hum Hypertens; 1990 Dec; 4(6):687-91. PubMed ID: 2096211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep, clonidine, and their interactive effect on growth hormone secretion in normal men.
    Cavallo A; Carskadon MA; Rosekind MR; Cattell-Harvey G
    Psychoneuroendocrinology; 1990; 15(1):15-21. PubMed ID: 2195577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to growth hormone-releasing hormone (GHRH), insulin, clonidine and arginine after GHRH pretreatment in obese children: evidence of somatostatin increase?
    Volta C; Bernasconi S; Iughetti L; Ghizzoni L; Rossi M; Costa M; Cozzini A
    Eur J Endocrinol; 1995 Jun; 132(6):716-21. PubMed ID: 7788012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired growth hormone response to clonidine in obesity.
    Altomonte L; Zoli A; Mirone L; Berchicci M; Travaglini R; Pellicano P; Greco AV
    Exp Clin Endocrinol; 1988 Dec; 92(2):231-4. PubMed ID: 3243343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fetal ethanol exposure on the in vitro release of growth hormone, somatostatin and growth hormone-releasing factor induced by clonidine and growth hormone feedback in male and female rats.
    Conway S; Ling SY; Leidy JW; Blaine K; Holtzman T
    Alcohol Clin Exp Res; 1997 Aug; 21(5):826-39. PubMed ID: 9267532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of modulating role of testosterone in growth hormone response to clonidine in essential hypertension.
    Koshida H; Miyamori I; Takasaki H; Takeda R
    Clin Exp Hypertens A; 1989; 11(8):1595-605. PubMed ID: 2612023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone secretion in hypertensive patients: evidence for a derangement in central adrenergic function.
    Barbieri C; Ferrari C; Caldara R; Curtarelli G
    Clin Sci (Lond); 1980 Feb; 58(2):135-8. PubMed ID: 7357832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone responses to clonidine and GRF in spontaneously hypertensive rats: neuroendocrine evidence for an enhanced responsiveness of brain alpha 2-adrenoceptors in genetical hypertension.
    Eriksson E; Dellborg M; Söderpalm B; Carlsson M; Nilsson C
    Life Sci; 1986 Dec; 39(22):2103-9. PubMed ID: 3023778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
    Tancer ME; Stein MB; Uhde TW
    Psychoneuroendocrinology; 1990; 15(4):253-9. PubMed ID: 2087535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central alpha-2 adrenergic function in patients with essential hypertension. Comparative study of growth hormone (GH) secretion stimulated by clonidine and GH-releasing hormone.
    Giustina A; Doga M; Bossoni S; Bodini C; Legati F; Pizzocolo G; Romanelli G
    Horm Metab Res; 1990 Aug; 22(8):451-2. PubMed ID: 2172136
    [No Abstract]   [Full Text] [Related]  

  • 13. Deranged alpha-adrenergic regulation of growth hormone secretion in poorly controlled diabetes: reversal of the exaggerated response to clonidine after continuous subcutaneous insulin infusion.
    Topper E; Gertner J; Amiel S; Press M; Genel M; Tamborlane WV
    Pediatr Res; 1985 Jun; 19(6):534-6. PubMed ID: 2989759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
    Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW; Tancer ME; Rubinow DR; Roscow DB; Boulenger JP; Vittone B; Gurguis G; Geraci M; Black B; Post RM
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults.
    Kimber J; Sivenandan M; Watson L; Mathias CJ
    Growth Horm IGF Res; 2001 Apr; 11(2):128-35. PubMed ID: 11472079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic clonidine administration on GH secretion in adult human subjects.
    Catania A; Baldini M; Orsatti A; Airaghi L; Gasparini P; Cantalamessa L
    Exp Clin Endocrinol; 1991 Mar; 97(1):76-80. PubMed ID: 1907565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH.
    Bamberger CM; Mönig H; Mill G; Gödde E; Schulte HM
    Exp Clin Endocrinol Diabetes; 1995; 103(3):205-8. PubMed ID: 7584524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
    Tanaka K; Inoue S; Numata K; Okazaki H; Nakamura S; Takamura Y
    Metabolism; 1990 Sep; 39(9):892-6. PubMed ID: 2118219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.